AMZN
Amazon.com, Inc.
AMZN has the edge over ATAT overall, supported by stronger modeled upside and stronger valuation.
ATAT
Atour Lifestyle Holdings Limited
ATAT offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
ATAT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
ATAT's revenue, profitability, cash flow and balance sheet are all currently strong.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over ATAT in the historical PE scenario, which offers more potential upside but is not a forecast.
ATAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 17x | $36.87 | — |
| Cheap | 18x | $37.84 | +2.6% |
| Fair | 25x | $53.81 | +46% |
| Expensive | 45x | $95.80 | +160% |
Historical ranges are pointers, not guarantees.
ATAT's PE is 17x, but its earnings don't support one, so it isn't a reliable read right now.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over ATAT on the outlook, with more favorable profitability expectations.
ATAT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for ATAT, with profitability holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN's earnings per share have climbed steadily: $12.37 over the past year, up 75% from the year before, and higher year over year for 14 quarters in a row. Its recent earnings include one-off gains.
ATAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $2.12 | +42% |
| Q1 2026 | $1.98 | +46% |
| Q4 2025 | $1.74 | +46% |
| Q3 2025 | $1.58 | +72% |
| Q2 2025 | $1.49 | +91% |
| Q1 2025 | $1.36 | +92% |
| Q4 2024 | $1.19 | +86% |
| Q3 2024 | $0.92 | +100% |
ATAT has the edge over AMZN on earnings, with stronger typical year-over-year growth.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
ATAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $522.3M | +41% |
| Q1 2026 | $421.9M | +48% |
| Q4 2025 | $418.4M | +34% |
| Q3 2025 | $394.4M | +38% |
| Q2 2025 | $370.5M | +37% |
| Q1 2025 | $286M | +30% |
| Q4 2024 | $312.8M | +38% |
| Q3 2024 | $284.9M | +47% |
ATAT has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 21% | -3.3 points |
| Q1 2026 | 24% | +4.9 points |
| Q4 2025 | 25% | +5.4 points |
| Q3 2025 | 25% | -1.1 points |
| Q2 2025 | 24% | +2.4 points |
| Q1 2025 | 19% | -3.5 points |
| Q4 2024 | 20% | +5.6 points |
| Q3 2024 | 26% | -0.4 points |
ATAT has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
ATAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $123.4M | +12% |
| Q1 2026 | $43M | +$45.6M |
| Q4 2025 | $85.2M | -0.9% |
| Q3 2025 | $90.8M | +48% |
| Q2 2025 | $110.7M | +33% |
| Q1 2025 | -$2.6M | -113% |
| Q4 2024 | $86M | +3.4% |
| Q3 2024 | $61.3M | -24% |
ATAT has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
ATAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.3% | -1.8M shares |
| 1 year | -2.2% | -3.1M shares |
| 3 years | -1% | -1.4M shares |
| 5 years | +1.2% | +1.7M shares |
| Available history | +8.9% | +11.2M shares |
ATAT has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $54M |
| Q1 2026 | $58.6M |
| Q4 2025 | $35.7M |
| Q3 2025 | $12.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
ATAT spent $161M buying back its own shares over the past year, after none the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
ATAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.9x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | -1.1x | Net Cash |
| Q3 2024 | -0.7x | Net Cash |
ATAT has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
ATAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.6 | Neutral |
| Stochastic | 68.9 | Neutral |
ATAT's weekly RSI is 60 (neutral) and its Stochastic is 69 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
ATAT PE vs Consumer Cyclical Sector
| Metric | ATAT | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 3.5% below |
| PE % | 11 | 46 | 35 pts below |
ATAT has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
ATAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.5 | 10% above |
| 20 week MA | $33.5 | 10% above |
| 50 week MA | $35.8 | 2.9% above |
| 100 week MA | $34.1 | 8.3% above |
| 200 week MA | $27.1 | 36% above |
ATAT is in an uptrend: it's above all five of its weekly moving averages, and 36% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over ATAT on returns for 2026, with the stronger performance.
ATAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $12.9 | $18.5 | +44% |
| 2023 | $18.5 | $17.4 | -6.2% |
| 2024 | $17.4 | $27.0 | +56% |
| 2025 | $27.0 | $41.7 | +55% |
| 2026 YTD | $41.7 | $36.9 | -12% |
ATAT has finished higher in three of the last four years, two of them by more than 50%. It's down 12% so far in 2026.